Edoxaban vs. Warfarin for Stroke Prevention for Patients with Atrial Fibrillation

被引：0
|
作者：
Diener, H. C.
机构：
来源：
AKTUELLE NEUROLOGIE | 2014年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E52 / E52
页数：1
相关论文
共 50 条
  • [1] Atrial Fibrillation Edoxaban vs. Warfarin: same Effect against Stroke
    Ruchalla, Elke
    [J]. AKTUELLE KARDIOLOGIE, 2014, 3 (02) : 83 - 84
  • [2] Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation
    Plitt, Anna
    Giugliano, Robert P.
    [J]. FUTURE CARDIOLOGY, 2014, 10 (02) : 153 - 155
  • [3] Edoxaban for the prevention of stroke in patients with atrial fibrillation
    Escobar Cervantes, Carlos
    Luis Merino, Jose
    Barrios, Vivencio
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (04) : 319 - 330
  • [4] Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation
    O'Donoghue, Michelle L.
    Ruff, Christian T.
    Giugliano, Robert P.
    Murphy, Sabina A.
    Grip, Laura T.
    Mercuri, Michele F.
    Rutman, Howard
    Shi, Minggao
    Kania, Grzegorz
    Cermak, Ondrej
    Braunwald, Eugene
    Antman, Elliott M.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (23) : 1470 - +
  • [5] Rivaroxaban Vs Warfarin for Stroke Prevention in Patients With Atrial Fibrillation Undergoing TAVR
    Okoh, Alexis K.
    Singh, Swaiman
    Khakwani, Zain
    Chen, Chunguang
    Russo, Mark
    Cohen, Marc
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S51 - S52
  • [6] Edoxaban versus Warfarin in Patients with Atrial Fibrillation
    Giugliano, Robert P.
    Ruff, Christian T.
    Braunwald, Eugene
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Halperin, Jonathan L.
    Waldo, Albert L.
    Ezekowitz, Michael D.
    Weitz, Jeffrey I.
    Spinar, Jindrich
    Ruzyllo, Witold
    Ruda, Mikhail
    Koretsune, Yukihiro
    Betcher, Joshua
    Shi, Minggao
    Grip, Laura T.
    Patel, Shirali P.
    Patel, Indravadan
    Hanyok, James J.
    Mercuri, Michele
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22): : 2093 - 2104
  • [7] Edoxaban versus Warfarin in patients with atrial fibrillation
    Meras Colunga, P.
    [J]. REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 346 - 346
  • [8] Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation?
    Hankey, GJ
    Klijn, CJM
    Eikelboom, JW
    [J]. STROKE, 2004, 35 (02) : 389 - 391
  • [9] Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation - A Randomized trial
    Albers, GW
    Diener, HC
    Frison, L
    Grind, M
    Nevinson, M
    Partridge, S
    Halperin, JL
    Horrow, J
    Olsson, SB
    Petersen, P
    Vahanian, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06): : 690 - 698
  • [10] A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
    Lip, Gregory Y. H.
    Merino, Jose
    Ezekowitz, Michael
    Ellenbogen, Kenneth
    Zamoryakhin, Dmitry
    Lanz, Hans
    Jin, James
    Al-Saadi, Naab
    Mercuri, Michele
    Goette, Andreas
    [J]. AMERICAN HEART JOURNAL, 2015, 169 (05) : 597 - U28
12345